Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
10 2019
Historique:
received: 03 12 2018
revised: 03 03 2019
accepted: 05 03 2019
pubmed: 20 3 2019
medline: 23 10 2019
entrez: 20 3 2019
Statut: ppublish

Résumé

Bleeding is the most common severe complication after endoscopic mucosal resection of large colon polyps and is associated with significant morbidity and cost. We examined whether prophylactic closure of the mucosal defect with hemoclips after polyp resection reduces the risk of bleeding. We performed a multicenter, randomized trial of patients with a large nonpedunculated colon polyp (≥20 mm) at 18 medical centers in North America and Spain from April 2013 through October 2017. Patients were randomly assigned to groups that underwent endoscopic closure with a clip (clip group) or no closure (control group) and followed. The primary outcome, postprocedure bleeding, was defined as a severe bleeding event that required hospitalization, a blood transfusion, colonoscopy, surgery, or another invasive intervention within 30 days after completion of the colonoscopy. Subgroup analyses included postprocedure bleeding with polyp location, polyp size, or use of periprocedural antithrombotic medications. We also examined the risk of any serious adverse event. A total of 919 patients were randomly assigned to groups and completed follow-up. Postprocedure bleeding occurred in 3.5% of patients in the clip group and 7.1% in the control group (absolute risk difference [ARD] 3.6%; 95% confidence interval [CI] 0.7%-6.5%). Among 615 patients (66.9%) with a proximal large polyp, the risk of bleeding in the clip group was 3.3% and in the control group was 9.6% (ARD 6.3%; 95% CI 2.5%-10.1%); among patients with a distal large polyp, the risks were 4.0% in the clip group and 1.4% in the control group (ARD -2.6%; 95% CI -6.3% to -1.1%). The effect of clip closure was independent of antithrombotic medications or polyp size. Serious adverse events occurred in 4.8% of patients in the clip group and 9.5% of patients in the control group (ARD 4.6%; 95% CI 1.3%-8.0%). In a randomized trial, we found that endoscopic clip closure of the mucosal defect following resection of large colon polyps reduces risk of postprocedure bleeding. The protective effect appeared to be restricted to large polyps located in the proximal colon. ClinicalTrials.gov no: NCT01936948.

Sections du résumé

BACKGROUND & AIMS
Bleeding is the most common severe complication after endoscopic mucosal resection of large colon polyps and is associated with significant morbidity and cost. We examined whether prophylactic closure of the mucosal defect with hemoclips after polyp resection reduces the risk of bleeding.
METHODS
We performed a multicenter, randomized trial of patients with a large nonpedunculated colon polyp (≥20 mm) at 18 medical centers in North America and Spain from April 2013 through October 2017. Patients were randomly assigned to groups that underwent endoscopic closure with a clip (clip group) or no closure (control group) and followed. The primary outcome, postprocedure bleeding, was defined as a severe bleeding event that required hospitalization, a blood transfusion, colonoscopy, surgery, or another invasive intervention within 30 days after completion of the colonoscopy. Subgroup analyses included postprocedure bleeding with polyp location, polyp size, or use of periprocedural antithrombotic medications. We also examined the risk of any serious adverse event.
RESULTS
A total of 919 patients were randomly assigned to groups and completed follow-up. Postprocedure bleeding occurred in 3.5% of patients in the clip group and 7.1% in the control group (absolute risk difference [ARD] 3.6%; 95% confidence interval [CI] 0.7%-6.5%). Among 615 patients (66.9%) with a proximal large polyp, the risk of bleeding in the clip group was 3.3% and in the control group was 9.6% (ARD 6.3%; 95% CI 2.5%-10.1%); among patients with a distal large polyp, the risks were 4.0% in the clip group and 1.4% in the control group (ARD -2.6%; 95% CI -6.3% to -1.1%). The effect of clip closure was independent of antithrombotic medications or polyp size. Serious adverse events occurred in 4.8% of patients in the clip group and 9.5% of patients in the control group (ARD 4.6%; 95% CI 1.3%-8.0%).
CONCLUSIONS
In a randomized trial, we found that endoscopic clip closure of the mucosal defect following resection of large colon polyps reduces risk of postprocedure bleeding. The protective effect appeared to be restricted to large polyps located in the proximal colon. ClinicalTrials.gov no: NCT01936948.

Identifiants

pubmed: 30885778
pii: S0016-5085(19)33573-5
doi: 10.1053/j.gastro.2019.03.019
pmc: PMC8224988
mid: NIHMS1714388
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01936948']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

977-984.e3

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001109
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Références

Gastrointest Endosc. 2013 Mar;77(3):401-7
pubmed: 23317580
Gastrointest Endosc. 2002 Mar;55(3):371-5
pubmed: 11868011
Am J Gastroenterol. 2016 Aug;111(8):1115-22
pubmed: 27296942
Gastrointest Endosc. 2015 Nov;82(5):904-9
pubmed: 25975527
Am J Gastroenterol. 2011 Jun;106(6):1119-24
pubmed: 21266961
Clin Gastroenterol Hepatol. 2012 Sep;10(9):969-79
pubmed: 22642950
Endoscopy. 2018 Jul;50(7):684-692
pubmed: 29370584
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1140-7
pubmed: 27033428
Gastrointest Endosc. 2004 Aug;60(2):234-41
pubmed: 15278051
Gut. 2016 May;65(5):806-20
pubmed: 25681402
Gastroenterology. 2011 Jun;140(7):1909-18
pubmed: 21392504
Clin Gastroenterol Hepatol. 2014 Apr;12(4):651-61.e1-3
pubmed: 24090728
Gastrointest Endosc. 2015 Jan;81(1):81-9
pubmed: 25442089
Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43
pubmed: 14652541
Scand J Gastroenterol. 2007 Jul;42(7):859-66
pubmed: 17558911
Digestion. 2010;82(4):213-20
pubmed: 20588036
Gastrointest Endosc. 2002 Mar;55(3):390-6
pubmed: 11868015
J Dig Dis. 2013 Mar;14(3):140-6
pubmed: 23134152
Gastrointest Endosc. 2012 Aug;76(2):255-63
pubmed: 22657404
Gastrointest Endosc. 2009 Nov;70(5):969-75
pubmed: 19640519
Dig Dis Sci. 2014 Apr;59(4):823-8
pubmed: 24526499
Endoscopy. 2017 Mar;49(3):270-297
pubmed: 28212588
Gastrointest Endosc. 2009 Dec;70(6):1128-36
pubmed: 19748615
Gastrointest Endosc. 2018 Jan;87(1):243-250.e2
pubmed: 28408327
Endoscopy. 2008 Feb;40(2):115-9
pubmed: 18253906
Am J Gastroenterol. 2018 Mar;113(3):317-321
pubmed: 29112201
Gastrointest Endosc. 2009 Dec;70(6):1060-70
pubmed: 19889407
Endoscopy. 2005 Nov;37(11):1116-22
pubmed: 16281142

Auteurs

Heiko Pohl (H)

Dartmouth Geisel School of Medicine, Hanover, New Hampshire; Section of Gastroenterology and Hepatology, VA White River Junction, White River Junction, Vermont. Electronic address: Heiko.pohl@dartmouth.edu.

Ian S Grimm (IS)

Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Matthew T Moyer (MT)

Division of Gastroenterology and Hepatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.

Muhammad K Hasan (MK)

Center for Interventional Endoscopy, Florida Hospital, Orlando, Florida.

Douglas Pleskow (D)

Division of Gastroenterology Beth Israel Deaconess Medical Center, Boston, Massachusetts.

B Joseph Elmunzer (BJ)

Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, South Carolina.

Mouen A Khashab (MA)

Division of Gastroenterology and Hepatology, Johns Hopkins Hospital, Baltimore, Maryland.

Omid Sanaei (O)

Division of Gastroenterology and Hepatology, Johns Hopkins Hospital, Baltimore, Maryland.

Firas H Al-Kawas (FH)

Division of Gastroenterology and Hepatology, Johns Hopkins University, Sibley Memorial Hospital, Washington, DC.

Stuart R Gordon (SR)

Dartmouth Geisel School of Medicine, Hanover, New Hampshire; Department of Gastroenterology and Hepatology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.

Abraham Mathew (A)

Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

John M Levenick (JM)

Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Harry R Aslanian (HR)

Section of Digestive Diseases, Yale-New Haven Hospital, New Haven, Connecticut.

Fadi Antaki (F)

Division of Gastroenterology, John D. Dingell Veterans Affairs Medical Center and Wayne State University, Detroit, Michigan.

Daniel von Renteln (D)

Division of Gastroenterology, University of Montreal Medical Center (CHUM) and Research Center (CRCHUM), Montreal, QC, Canada.

Seth D Crockett (SD)

Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Amit Rastogi (A)

Division of Gastroenterology, Hepatology and Motility, University of Kansas Medical Center, Kansas City, Kansas.

Jeffrey A Gill (JA)

Division of Gastroenterology James A. Haley VA, University of South Florida, Tampa, Florida.

Ryan J Law (RJ)

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.

Pooja A Elias (PA)

Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, South Carolina.

Maria Pellise (M)

Gastroenterology Department, Hospital Clínic de Barcelona, Barcelona, Spain.

Michael B Wallace (MB)

Division of Gastroenterology and Hepatology, Mayo Clinic Jacksonville, Jacksonville, Florida.

Todd A Mackenzie (TA)

The Dartmouth Institute, Department for Biomedical Data Science, Lebanon, New Hampshire.

Douglas K Rex (DK)

Indiana University School of Medicine, Indianapolis, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH